Related Experiment Video
Updated: Jul 26, 2025
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct
Magali Noval Rivas1, Moshe Arditi2
1Division of Infectious Diseases and Immunology, Department of Pediatrics, Guerin Children's at Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Biomedical Sciences, Infectious and Immunologic Diseases Research Center (IIDRC), Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Insights
Multisystem inflammatory syndrome in children (MIS-C) is a post-SARS-CoV-2 condition. MIS-C shares more features with toxic shock syndrome than Kawasaki disease, guiding treatment strategies.
Area of Science:
- Pediatric rheumatology
- Infectious diseases
- Immunology
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition following SARS-CoV-2 infection.
- Initially, MIS-C was often compared to Kawasaki disease (KD), a known pediatric vasculitis.
- Understanding the distinct features of MIS-C is crucial for appropriate management.
Purpose of the Study:
- To differentiate MIS-C from Kawasaki disease.
- To elucidate the clinical and immunological characteristics of MIS-C.
- To inform potential therapeutic strategies for MIS-C.
Main Methods:
- Comparative analysis of epidemiological data.
- Clinical feature assessment.
- Immunological marker evaluation.
- Pathological examination.
Main Results:
- MIS-C and KD exhibit significant differences in epidemiology, clinical presentation, and pathology.
- MIS-C shares more clinical and laboratory similarities with toxic shock syndrome (TSS) than with KD.
- Distinct immunological profiles differentiate MIS-C from KD.
Conclusions:
- MIS-C is a distinct entity from Kawasaki disease.
- The association of MIS-C with TSS offers insights into its pathogenesis.
- Recognizing MIS-C's unique characteristics is vital for developing targeted therapies.
Abstract:
Multisystem inflammatory syndrome in children (MIS-C) is a delayed postinflammatory disorder associated with the previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially, MIS-C was described as highly similar to Kawasaki disease (KD), a pediatric febrile systemic vasculitis that can lead to the development of coronary artery aneurysms (CAAs). While KD and MIS-C are both inflammatory disorders, the 2 entities differ in their epidemiological, clinical, immunological, and pathological features. MIS-C clinical and laboratory characteristics are more closely related to toxic shock syndrome (TSS) than KD, which informs the understanding of pathogenesis and potential therapeutic approaches.
More Related Videos
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
01:20The JAK-STAT Signaling Pathway
02:26NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:21Myocarditis I: Introduction
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...